D.E. Shaw & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.76M | Buy |
126,800
+49,700
| +64% | +$962K | ﹤0.01% | 2670 |
|
|
2025
Q4 | $1.66M | Sell |
77,100
-6,500
| -8% | -$137K | ﹤0.01% | 3200 |
|
|
2025
Q3 | $1.61M | Sell |
83,600
-2,900
| -3% | -$51.7K | ﹤0.01% | 3133 |
|
|
2025
Q2 | $1.48M | Buy |
+86,500
| New | +$3.69M | ﹤0.01% | 2958 |
|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$1.1M | – | 5152 |
|
|
2022
Q3 | $1.1M | Buy |
+10,000
| New | +$1.01M | ﹤0.01% | 3521 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$1.6M | – | 4182 |
|
|
2020
Q2 | $1.6M | Sell |
10,000
-70,100
| -88% | -$9.54M | ﹤0.01% | 2581 |
|
|
2020
Q1 | $7.83M | Buy |
80,100
+18,900
| +31% | +$2.16M | 0.02% | 1137 |
|
|
2019
Q4 | $7.9M | Sell |
61,200
-10,000
| -14% | -$1.01M | 0.01% | 1379 |
|
|
2019
Q3 | $5.36M | Buy |
71,200
+56,200
| +375% | +$6.64M | 0.01% | 1595 |
|
|
2019
Q2 | $2.28M | Sell |
15,000
-300
| -2% | -$36.5K | ﹤0.01% | 2152 |
|
|
2019
Q1 | $1.82M | Sell |
15,300
-20,000
| -57% | -$2.57M | ﹤0.01% | 2214 |
|
|
2018
Q4 | $3.85M | Buy |
35,300
+33,900
| +2,421% | +$4.24M | 0.01% | 1685 |
|
|
2018
Q3 | $226K | Buy |
+1,400
| New | +$191K | ﹤0.01% | 3495 |
|
|
2018
Q1 | – | Sell |
-30,500
| Closed | -$1.7M | – | 3796 |
|
|
2017
Q4 | $1.7M | Hold |
30,500
| – | – | ﹤0.01% | 2256 |
|
|
2017
Q3 | $1.38M | Sell |
30,500
-200
| -0.7% | -$7.99K | ﹤0.01% | 2279 |
|
|
2017
Q2 | $1.03M | Hold |
30,700
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q1 | $909K | Hold |
30,700
| – | – | ﹤0.01% | 2356 |
|
|
2016
Q4 | $842K | Buy |
+30,700
| New | +$1.23M | ﹤0.01% | 2558 |
|
|
2014
Q4 | – | Sell |
-40,000
| Closed | -$844K | – | 4286 |
|
|
2014
Q3 | $844K | Buy |
40,000
+29,200
| +270% | +$659K | ﹤0.01% | 2951 |
|
|
2014
Q2 | $322K | Buy |
+10,800
| New | +$341K | ﹤0.01% | 3798 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM